US88032L5066 - Common Stock - After market: 1.8 +0.05 (+2.86%)
NASDAQ:TENX (2/3/2023, 7:10:48 PM)-0.46 (-20.81%)
|GICS Sector||Health Care|
|Earnings (Last)||11-10 2022-11-10/amc||Earnings (Next)||03-27 2023-03-27/amc|
|Ins Owners||203.87%||Inst Owners||151.22%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
Tenax Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Chapel Hill, North Carolina and currently employs 8 full-time employees. Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need. The firm's products include TNX-103 (oral levosimendan) and TNX-201 (oral enteric coated imatinib). The firm's lead product, Levosimendan, is a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure. TNX-201 is for the treatment of pulmonary arterial hypertension (PAH), which is a fatal orphan disease. The firm has completed Phase II clinical trial of levosimendan in North America for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF).
TENAX THERAPEUTICS INC
101 Glen Lennox Drive, Suite 300
Chapel Hill NORTH CAROLINA 27560
CEO: Anthony DiTonno
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Tenax Therapeutics (TENX) shares fell 14% after the pharmaceutical company priced its $15.6M securities offering.The offering comrpises 8.66M shares of common stock (or pre-funded...
CHAPEL HILL, N.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying,...
Here you can normally see the latest stock twits on TENX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.